The biotin label acts as the molecular attachment point for the detection reagent. After a biotinylated antibody, antigen, or nucleic acid probe participates in target recognition, streptavidin binds the attached biotin and brings HRP to the assay location. This arrangement separates target recognition from signal generation, allowing different capture or probe molecules to use the same detection principle.
HRP converts an added substrate into a measurable product, which may produce either visible color or chemiluminescence. The enzyme therefore transforms the molecular binding event into an observable assay signal. Depending on the assay format, that signal can indicate the presence of a target or support measurement of molecular interactions and immune responses.
The system reports where the biotinylated recognition component has associated with its target, while HRP produces a detectable reaction at that site. In formats such as ELISA, the resulting signal supports measurement. In tissue staining, the reaction helps localize targets within the sample. Thus, the same binding and enzyme principles provide either measurement or spatial information.
A typical workflow begins with a biotinylated antibody, antigen, or nucleic acid probe that recognizes the target. The Streptavidin-HRP Complex is then introduced so streptavidin can bind the available biotin. Adding an appropriate substrate allows HRP to generate a colored or chemiluminescent product, producing the readout used to detect or measure the target.
The reagent is used in ELISA, immunoblotting, and tissue staining. Across these formats, biotinylated recognition molecules provide the connection to the target, while HRP supplies the measurable readout. The resulting signal can help researchers detect immune-related molecules, examine molecular interactions, or determine where a target is present in a biological sample.
In immunology and infection studies, the system can detect immune responses, pathogen-associated molecules, and infection biomarkers. A biotinylated antibody, antigen, or nucleic acid probe provides target specificity, while HRP converts binding into a measurable signal. This combination supports both quantitative immunoassays and localization studies, including investigations that use tissue staining to identify targets in biological samples.